| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |